A.10 Cladribine, glatiramer and rituximab - multiple sclerosis - EML

Application, expert reviews and public comments

Application

Inclusion of Cladribine, glatiramer and rituximab - multiple sclerosis - EML

Expert reviews

Expert Review 1

Expert Review 2

Expert Review 3

Comments

Clinton Health Access Initiative

F. Hoffmann-La Roche Ltd

Institute for Clinical and Economic Review

WHO Department Comments

Mental Health and Substance Use